Study Summary
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
Want to learn more about this trial?
Request More InfoInterventions
MB-CART19.1BIOLOGICAL
Assessment of long-term safety and efficacy of MB-CART19.1 treatment.
MB-CART20.1BIOLOGICAL
Assessment of long-term safety and efficacy of MB-CART20.1 treatment.
MB-CART2019.1BIOLOGICAL
Assessment of long-term safety and efficacy of MB-CART2019.1 treatment.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Charité Universitätsmedizin Berlin | Berlin | Germany | |
| Universitätsklinikum Köln | Cologne | Germany | |
| Uniklinikum Erlangen | Erlangen | Germany | |
| Universitätsmedizin Göttingen | Göttingen | Germany | |
| Universitätsklinikum Münster | Münster | Germany | |
| Universitätsklinikum Tübingen | Tübingen | Germany | |
| Universitäts-Kinderklinik Würzburg | Würzburg | Germany |